Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / ADMS - Adamas Pharmaceuticals: Unjustified Sell-Off Following Another Strong Quarter

ADMS - Adamas Pharmaceuticals: Unjustified Sell-Off Following Another Strong Quarter

Adamas Pharmaceuticals Inc.
  • Adamas Pharmaceuticals recently reported its Q3 earnings with a slight beat on EPS and a slight miss on revenue. The company did report record product sales for GOCOVRI.
  • Adamas looks to have found a rhythm for GOCOVRI and the commericial numbers continue to improve. In addition,i t is now collecting royalties for NAMZARIC.
  • After making some drastic moves to manage my Adamas position, I have decided to reload on top of my core position in anticipation that the company will be able to breakeven.

For further details see:

Adamas Pharmaceuticals: Unjustified Sell-Off Following Another Strong Quarter
Stock Information
Company Name: Adamas Pharmaceuticals Inc.
Stock Symbol: ADMS
Market: NASDAQ
Website: adamaspharma.com
Menu
ADMS ADMS Quote ADMS Short ADMS News ADMS Articles ADMS Message Board
Get ADMS Alerts

News, Short Squeeze, Breakout and More Instantly...